HIGHLIGHTS
- who: Zhenyu Dai from the Tongji Hospital Huazhong University Biotherapeutics, Nanjing, Jiangsu, China have published the article: The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains, in the Journal: (JOURNAL)
- what: The authors report the selection of novel CD5-targeting fully human heavy-chain variable (FHVH) domains for the development of a biepitopic CAR termed FHVH3/VH1 containing FHVH1 and FHVH3 which were validated to bind different epitopes of the CD5 antigen.
- how: The results showed that FHVH3/VH1 CAR-T_cells cleared T-ALL cells . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.